The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice

Takafumi Fuchiwaki, Xun Sun, Kenjiro Fujimura, Hisakata Yamada, Kensuke Shibata, Hiromi Muta, Eckhard R. Podack, Hideyuki Kawauchi, Yasunobu Yoshikai

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

CD30 ligand (CD30L) plays an important role in the amplification and/or activation of effector CD4 + T cells, irrespective of Th cell subset. To examine the role of CD30L in allergic rhinitis, we evaluated an OVA model of allergic rhinitis in CD30L knock out (KO) mice on a BALB/c background sensitized with OVA. Symptoms of allergic rhinitis such as eosinophil infiltration into the nasal mucosa were drastically diminished in OVA-sensitized CD30L KO mice following intranasal challenge with OVA. The levels of OVA-specific IgE in the sera and the Th2 response in nasopharynx-associated lymphoid tissues and cervical LNs of CD30L KO mice were significantly lower than those of WT mice following intranasal challenge with OVA. Intranasal administration of CD30-Ig during the effector phase with OVA significantly prevented the development of allergic rhinitis in WT mice. These results suggest that CD30L plays an important role in allergic rhinitis and that the inhibition of CD30L/CD30 signaling might be useful as a novel biological therapy for allergic rhinitis.

Original languageEnglish
Pages (from-to)2947-2954
Number of pages8
JournalEuropean Journal of Immunology
Volume41
Issue number10
DOIs
Publication statusPublished - Oct 1 2011

Fingerprint

CD30 Ligand
Knockout Mice
Intranasal Administration
Biological Therapy
Nasopharynx
Nasal Mucosa
Lymphoid Tissue
Allergic Rhinitis
Eosinophils
Immunoglobulin E
T-Lymphocytes

All Science Journal Classification (ASJC) codes

  • Immunology
  • Immunology and Allergy

Cite this

The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice. / Fuchiwaki, Takafumi; Sun, Xun; Fujimura, Kenjiro; Yamada, Hisakata; Shibata, Kensuke; Muta, Hiromi; Podack, Eckhard R.; Kawauchi, Hideyuki; Yoshikai, Yasunobu.

In: European Journal of Immunology, Vol. 41, No. 10, 01.10.2011, p. 2947-2954.

Research output: Contribution to journalArticle

Fuchiwaki, T, Sun, X, Fujimura, K, Yamada, H, Shibata, K, Muta, H, Podack, ER, Kawauchi, H & Yoshikai, Y 2011, 'The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice', European Journal of Immunology, vol. 41, no. 10, pp. 2947-2954. https://doi.org/10.1002/eji.201141423
Fuchiwaki, Takafumi ; Sun, Xun ; Fujimura, Kenjiro ; Yamada, Hisakata ; Shibata, Kensuke ; Muta, Hiromi ; Podack, Eckhard R. ; Kawauchi, Hideyuki ; Yoshikai, Yasunobu. / The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice. In: European Journal of Immunology. 2011 ; Vol. 41, No. 10. pp. 2947-2954.
@article{9a527a49da8c4aee962badc2750dcd77,
title = "The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice",
abstract = "CD30 ligand (CD30L) plays an important role in the amplification and/or activation of effector CD4 + T cells, irrespective of Th cell subset. To examine the role of CD30L in allergic rhinitis, we evaluated an OVA model of allergic rhinitis in CD30L knock out (KO) mice on a BALB/c background sensitized with OVA. Symptoms of allergic rhinitis such as eosinophil infiltration into the nasal mucosa were drastically diminished in OVA-sensitized CD30L KO mice following intranasal challenge with OVA. The levels of OVA-specific IgE in the sera and the Th2 response in nasopharynx-associated lymphoid tissues and cervical LNs of CD30L KO mice were significantly lower than those of WT mice following intranasal challenge with OVA. Intranasal administration of CD30-Ig during the effector phase with OVA significantly prevented the development of allergic rhinitis in WT mice. These results suggest that CD30L plays an important role in allergic rhinitis and that the inhibition of CD30L/CD30 signaling might be useful as a novel biological therapy for allergic rhinitis.",
author = "Takafumi Fuchiwaki and Xun Sun and Kenjiro Fujimura and Hisakata Yamada and Kensuke Shibata and Hiromi Muta and Podack, {Eckhard R.} and Hideyuki Kawauchi and Yasunobu Yoshikai",
year = "2011",
month = "10",
day = "1",
doi = "10.1002/eji.201141423",
language = "English",
volume = "41",
pages = "2947--2954",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "10",

}

TY - JOUR

T1 - The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice

AU - Fuchiwaki, Takafumi

AU - Sun, Xun

AU - Fujimura, Kenjiro

AU - Yamada, Hisakata

AU - Shibata, Kensuke

AU - Muta, Hiromi

AU - Podack, Eckhard R.

AU - Kawauchi, Hideyuki

AU - Yoshikai, Yasunobu

PY - 2011/10/1

Y1 - 2011/10/1

N2 - CD30 ligand (CD30L) plays an important role in the amplification and/or activation of effector CD4 + T cells, irrespective of Th cell subset. To examine the role of CD30L in allergic rhinitis, we evaluated an OVA model of allergic rhinitis in CD30L knock out (KO) mice on a BALB/c background sensitized with OVA. Symptoms of allergic rhinitis such as eosinophil infiltration into the nasal mucosa were drastically diminished in OVA-sensitized CD30L KO mice following intranasal challenge with OVA. The levels of OVA-specific IgE in the sera and the Th2 response in nasopharynx-associated lymphoid tissues and cervical LNs of CD30L KO mice were significantly lower than those of WT mice following intranasal challenge with OVA. Intranasal administration of CD30-Ig during the effector phase with OVA significantly prevented the development of allergic rhinitis in WT mice. These results suggest that CD30L plays an important role in allergic rhinitis and that the inhibition of CD30L/CD30 signaling might be useful as a novel biological therapy for allergic rhinitis.

AB - CD30 ligand (CD30L) plays an important role in the amplification and/or activation of effector CD4 + T cells, irrespective of Th cell subset. To examine the role of CD30L in allergic rhinitis, we evaluated an OVA model of allergic rhinitis in CD30L knock out (KO) mice on a BALB/c background sensitized with OVA. Symptoms of allergic rhinitis such as eosinophil infiltration into the nasal mucosa were drastically diminished in OVA-sensitized CD30L KO mice following intranasal challenge with OVA. The levels of OVA-specific IgE in the sera and the Th2 response in nasopharynx-associated lymphoid tissues and cervical LNs of CD30L KO mice were significantly lower than those of WT mice following intranasal challenge with OVA. Intranasal administration of CD30-Ig during the effector phase with OVA significantly prevented the development of allergic rhinitis in WT mice. These results suggest that CD30L plays an important role in allergic rhinitis and that the inhibition of CD30L/CD30 signaling might be useful as a novel biological therapy for allergic rhinitis.

UR - http://www.scopus.com/inward/record.url?scp=80053152865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053152865&partnerID=8YFLogxK

U2 - 10.1002/eji.201141423

DO - 10.1002/eji.201141423

M3 - Article

C2 - 21739429

AN - SCOPUS:80053152865

VL - 41

SP - 2947

EP - 2954

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 10

ER -